Evidence map›Paper›PMID 12399485›Full record

ArticleJournal of bacteriology2002

Proteins released by Helicobacter pylori in vitro.

Nayoung Kim, David L Weeks, Jai Moo Shin, David R Scott, Mary K Young, George Sachs

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of bacteriology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Review
  3. RecombinantAntibiotics (Basel, Switzerland) · 2022
    Review
  4. Review
  5. Review
  6. An Overview of Autophagy inFrontiers in cellular and infection microbiology · 2022
    Review
  7. Article
  8. AMicroorganisms · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Smoking,Cancer prevention research (Philadelphia, Pa.) · 2019
    Article
  14. Article
  15. Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Article
  16. Article
  17. Frontiers in cellular and infection microbiology · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Nayoung KimDepartment of Physiology and Medicine, UCLA Digestive Research Center, University of California, Los Angeles, and VA Greater Los Angeles Health Care System, 90073, USA.
David L Weeks
Jai Moo Shin
David R Scott
Mary K Young
George Sachs
University of California, Los Angeles · USBeckman Research InstituteVA Greater Los Angeles Healthcare System · US

Funding

GASTRIC ENTEROCHROMAFFIN-LIKE CELL IN ULCER DISEASER01DK046917 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SACHS, GEORGE · 1994 to 2005
$798k
NIDDK NIH HHS DK46917NIDDK NIH HHS R01 DK046917PHS HHS 17294PHS HHS 41301PHS HHS 53462
6 · The paper itself

Abstract

Secretion of proteins by Helicobacter pylori may contribute to gastric inflammation and epithelial damage. An in vitro analysis was designed to identify proteins released by mechanisms other than nonspecific lysis. The radioactivity of proteins in the supernatant was compared with that of the intact organism by two-dimensional gel phosphorimaging following a 4-h pulse-chase. The ratio of the amount of UreB, a known cytoplasmic protein, in the supernatant to that in the pellet was found to be 0.25, and this was taken as an index of lysis during the experiments (n = 6). Ratios greater than that of UreB were used to distinguish proteins that were selectively released into the medium. Thus, proteins enriched more than 10-fold in the supernatant compared to UreB were identified by mass spectrometry. Sixteen such proteins were present in the supernatant: VacA; a conserved secreted protein (HP1286); putative peptidyl cis-trans isomerase (HP0175); six proteins encoded by HP0305, HP0231, HP0973, HP0721, HP0129, and HP0902; thioredoxin (HP1458); single-stranded-DNA-binding 12RNP2 precursor (HP0827); histone-like DNA-binding protein HU (HP0835); ribosomal protein L11 (HP1202); a putative outer membrane protein (HP1564); and outer membrane proteins Omp21 (HP0913) and Omp20 (HP0912). All except HP0902, thioredoxin, HP0827, HP0835, and HP1202 had a signal peptide. When nalidixic acid, a DNA synthesis inhibitor, was added to inhibit cell division but not protein synthesis, to decrease possible contamination due to outer membrane shedding, two outer membrane proteins (Omp21 and Omp20) disappeared from the supernatant, and the amount of VacA also decreased. Thus, 13 proteins were still enriched greater than 10-fold in the medium after nalidixic acid treatment, suggesting these were released specifically, possibly by secretion. These proteins may be implicated in H. pylori-induced effects on the gastric epithelium.

Indexed as

Bacterial ProteinsBacteriological TechniquesCulture Media, ConditionedElectrophoresis, Gel, Two-DimensionalHelicobacter pyloriMass SpectrometryMethionineNalidixic AcidSulfur RadioisotopesBacterial ProteinsCulture Media, ConditionedMethionineNalidixic AcidSulfur Radioisotopes

Identifiers

PMID12399485
PMCPMC151949
OpenAlexW2091657927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.